OTCMKTS:CLPBY Coloplast A/S Q2 2025 Earnings Results & Report $7.35 -0.13 (-1.77%) As of 03:56 PM Eastern Coloplast A/S missed analyst expectations on both earnings and revenue in its Q2 2025 results, released May 6, 2025. The company reported EPS of $0.06 versus the $0.0874 consensus estimate, while revenue of $1.05 billion fell short of the $7.02 billion estimate by $5.97 billion. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ2 2025Report DateMay 6, 2025TimeBefore Market Opens Coloplast A/S EPS ResultsActual EPS$0.06Consensus EPS $0.0874Beat/MissMissed by -$0.0274One Year Ago EPSN/AEPS Beat Rate3 of last 8 quartersColoplast A/S Revenue ResultsActual Revenue$1.05 billionExpected Revenue$7.02 billionBeat/MissMissed by -$5.97 billionYoY Revenue GrowthN/AUpcoming EarningsColoplast A/S' next earnings date is estimated for Friday, February 5, 2027, based on past reporting schedules. Conference Call ResourcesEarnings HistoryCompany Profile Coloplast A/S Q2 2025 Earnings FAQ Did Coloplast A/S beat earnings estimates for Q2 2025? Coloplast A/S (OTCMKTS:CLPBY) reported earnings of $0.06 per share for Q2 2025, missing the consensus estimate of $0.0874. The report was announced on Tuesday, May 6, 2025. What was Coloplast A/S' revenue for Q2 2025? Coloplast A/S reported revenue of $1.05 billion for Q2 2025, against a consensus estimate of $7.02 billion. When is Coloplast A/S' next earnings date? Coloplast A/S' next earnings date is estimated for Friday, February 5, 2027. MarketBeat tracks confirmed and estimated earnings dates for Coloplast A/S on the company's earnings history page. Coloplast A/S Earnings HeadlinesCritical Comparison: Treace Medical Concepts (NASDAQ:TMCI) and Coloplast A/S (OTCMKTS:CLPBY)November 7, 2026 | americanbankingnews.comColoplast A/S (CLPBY) Q4 2026 Earnings Call TranscriptNovember 3, 2026 | seekingalpha.comBuy Stocks… A Crash is ComingThink stocks are expensive and a crash is coming? Economist Jim Rickards says you're right, but he urges investors not to sell before hearing his 2027 prediction. He warns that by November 30th, Congress is set to make a move he believes will trigger a historic buying panic. Economists call the phenomenon a crack-up boom. Rickards is known for correctly predicting the biggest market shocks of the last 20 years.November 18 at 1:00 AM | Paradigm Press (Ad)Coloplast pares back China operations as market recovery remains elusiveNovember 3, 2026 | reuters.comColoplast A/S - FY 2025/26 Earnings Release - Invitation for conference call on 3 November 2026 at 11.00am CETOctober 21, 2026 | marketscreener.comMCLPBY Share News TodayJune 22, 2026 | uk.investing.comSee More Coloplast A/S Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Coloplast A/S? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Coloplast A/S and other key companies, straight to your email. Email Address About Coloplast A/SColoplast A/S (OTCMKTS:CLPBY) is a Danish medical device company that develops and markets products and services for people with intimate health care needs. Its main business areas include ostomy care, continence care, wound and skin care, and urology care. Its products include ostomy bags and accessories, catheters and other continence products, wound dressings, and devices used in urological procedures. Coloplast also provides voice and respiratory care products, including solutions for people who have had a laryngectomy. Founded in Denmark in 1957, Coloplast serves customers in markets around the world. The company was established after nurse Elise Sørensen helped develop an ostomy bag for her sister, in collaboration with entrepreneur Aage Louis-Hansen.View Coloplast A/S ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes ShapeGeneral Motors Faces a Cost Squeeze as Factory Automation Takes Center StageNVIDIA's Earnings Were Strong, But Can the Next CEO Keep the Momentum Going?5 Consumer Discretionary Plays Showing Strength During the Tech Sell-OffAMD Bets $8.2B on Physical AI: Could Robotics Be Its Next Growth Frontier?Viking’s Low-Water Miss Looks Like a Buy-the-Dip OpportunityDisney Has the Magic Touch: Dividend Growth and Buybacks Could Fuel a Breakout Upcoming Earnings NetEase (11/19/2026)Alibaba Group (11/19/2026)PDD (11/19/2026)Ross Stores (11/19/2026)Walmart (11/19/2026)Intuit (11/19/2026)Hewlett Packard Enterprise (11/23/2026)Medtronic (11/24/2026)Analog Devices (11/24/2026)Autodesk (11/24/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.